Replies to post #93 on Abbott Laboratories (ABT)

[DewDiligence]

ABT ‘ReadMeFirst’ updated:

2Q11 sales of top products and franchises;
2Q11 sales in emerging markets +23% to $10.4B annualized rate;
Humira will be world’s biggest drug in 2012;
P/E based on 2011 guidance is only 11x;
JNJ withdraws from DES market;
60% of Xience sales are ex-US.

http://investorshub.advfn.com/boards/read_msg.aspx?message_id=65530410